The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Daptomycin 350 mg powder for solution for injection/infusion

hameln pharma gmbhPA2237/005/001

Main Information

Trade NameDaptomycin 350 mg powder for solution for injection/infusion
Active SubstancesDaptomycin
Dosage FormPowder for solution for injection/infusion
Licence Holderhameln pharma gmbh
Licence NumberPA2237/005/001

Group Information

ATC CodeJ01XX09 daptomycin


License statusAuthorised
Licence Issued09/12/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back